Company Filing History:
Years Active: 2018-2024
Title: Anne Schlegel: Innovator in Cancer Diagnostics
Introduction
Anne Schlegel is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmacogenomics, particularly in the detection of CpG methylation for cancer diagnosis. With a total of 3 patents to her name, her work has the potential to improve cancer detection methods significantly.
Latest Patents
One of her latest patents focuses on methods for detecting CpG methylation and diagnosing cancer. This invention relates to identifying the presence or absence of hypermethylated DNA. The detection of CpG methylation in marker DNA is crucial for cancer diagnosis, and her improved methods allow for more sensitive detection of methylated marker DNA, even in the presence of high backgrounds of unmethylated marker DNA.
Career Highlights
Throughout her career, Anne Schlegel has worked with notable companies such as Epigenomics AG and New Day Diagnostics, LLC. Her expertise in pharmacogenomics has positioned her as a key player in the development of innovative diagnostic methods.
Collaborations
Anne has collaborated with several professionals in her field, including Denise Kottwitz and Reimo Tetzner. These collaborations have further enhanced her research and contributions to cancer diagnostics.
Conclusion
Anne Schlegel's work in the field of cancer diagnostics exemplifies the impact of innovative thinking in healthcare. Her patents and collaborations continue to pave the way for advancements in cancer detection methods.